Faeth names Karen Vousden as class II director
Faeth Therapeutics appointed Karen Vousden, Ph.D. as a Class II director and added her to the Compensation Committee, effective September 11, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.